Xiao-Jun Du | Biochemistry | Best Review Article Award

Published on by Best Paper Awards
Best Researcher Award
Xiao-Jun Du — Baker Heart and Diabetes Institute, Australia
Xiao-Jun Du
Affiliation Baker Heart and Diabetes Institute
Country Australia
Scopus ID 7402551956
Documents 241
Citations 12,313
h-index 62
Subject Area Biochemistry
Event Best Paper Awards

Xiao-Jun Du is a researcher associated with the Baker Heart and Diabetes Institute, Australia, whose work contributes to the field of Biochemistry with emphasis on metabolic regulation and cardiovascular disease mechanisms. This article summarizes his academic profile, research output, and scholarly impact using bibliometric indicators such as Scopus records, citation metrics, and h-index evaluation. With 241 documents and 12,313 citations, his research demonstrates consistent contributions to biomedical science. The profile also discusses recognition through awards including the Best Paper Awards event. Overall, the study highlights his influence in translational research and potential suitability for scientific recognition and academic leadership globally.

Abstract

Xiao-Jun Du is a researcher associated with the Baker Heart and Diabetes Institute, Australia, whose work contributes to the field of Biochemistry with emphasis on metabolic regulation and cardiovascular disease mechanisms. This article summarizes his academic profile, research output, and scholarly impact using bibliometric indicators such as Scopus records, citation metrics, and h-index evaluation. With 241 documents and 12,313 citations, his research demonstrates consistent contributions to biomedical science. The profile also discusses recognition through awards including the Best Paper Awards event. Overall, the study highlights his influence in translational research and potential suitability for scientific recognition and academic leadership globally.

Keywords

Biochemistry; Cardiovascular Disease; Metabolic Regulation; Bibliometrics; Scopus; h-index; Translational Research; Biomedical Science

Introduction

Xiao-Jun Du is an academic researcher affiliated with the Baker Heart and Diabetes Institute, Australia, working in Biochemistry and related biomedical sciences. His research focuses on molecular mechanisms underlying cardiometabolic diseases. This article presents an overview of his scholarly metrics, publications, and academic recognition within global scientific communities worldwide impact.

Research Profile

Xiao-Jun Du’s research profile reflects extensive contributions to cardiovascular and metabolic biochemistry. He has authored numerous peer-reviewed publications and collaborated internationally. His academic output is indexed in Scopus, demonstrating sustained research productivity. The profile highlights his expertise in disease mechanisms, biomarker discovery, and translational biomedical research applications and innovation focus.

Research Contributions

His research contributions include significant advancements in understanding cardiovascular disease pathways and metabolic regulation. He has contributed to experimental studies identifying molecular targets for therapy development. His interdisciplinary work bridges basic science and clinical research, strengthening translational outcomes and supporting innovation in biomedical diagnostics and treatment strategies global research impact.

Publications

His publication record comprises articles in peer-reviewed international journals focusing on biochemistry, cardiometabolic disease, and molecular biology. Indexed databases such as Scopus reflect his consistent scholarly output. These publications contribute to advancing scientific understanding and support ongoing research collaborations across global academic institutions and interdisciplinary biomedical knowledge and expansion globally.

Research Impact

His research impact is evidenced by citation metrics, academic recognition, and contributions to high-impact biomedical studies. With over 12,313 citations and an h-index of 62, his work demonstrates strong influence in the scientific community. His findings support advancements in cardiovascular and metabolic disease research worldwide and translational science relevance globally.

Award Suitability

His academic profile indicates strong suitability for recognition in international scientific awards. His contributions to biochemistry and cardiovascular research demonstrate consistent excellence and innovation. The combination of high citation impact, extensive publications, and interdisciplinary collaboration positions him as a candidate for distinguished research honors and professional acknowledgment global academic recognition.

Conclusion

This overview highlights Xiao-Jun Du’s contributions to biochemistry and biomedical research, emphasizing his academic productivity and citation impact. His work continues to support advancements in cardiovascular and metabolic disease understanding. Ongoing research engagement ensures sustained relevance in global scientific discourse and future biomedical innovation and continued academic research excellence globally.

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Xiao-Jun Du, Author ID 7402551956. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7402551956
  2. Best Paper Awards. (n.d.). Official event information and recognition listing.
    https://bestpaperawards.com/

  3. Galectin-3 gene deletion alters lipid profile in healthy and cardiomyopathy mouse hearts.
    https://www.researchgate.net/publication/394312305_Galectin-3_gene_deletion_alters_lipid_profile_in_healthy_and_cardiomyopathy_mouse_hearts

P. V. G. K Sarma | Biochemistry | Editorial Board Member

Published on by Best Paper Awards

Assoc. Prof. Dr. P. V. G. K Sarma | Biochemistry | Editorial Board Member 

Associate Professor | Sri Venkateswara Institute of Medical Sciences | India

P. V. G. K. Sarma is a senior Indian biotechnologist and academic leader currently serving as the Head of the Department of Biotechnology at the Sri Venkateswara Institute of Medical Sciences, Tirupati, a position he has held since 2004, with his academic training from JNTU Hyderabad and a broad research portfolio reflected in over a hundred scholarly publications indexed across major journals. P. V. G. K. Sarma His core research spans genetic engineering, microbial biotechnology, functional genomics, structural bioinformatics, and stem cell differentiation with a strong translational focus on regenerative medicine and human disease. A major strength of his work lies in the in vitro differentiation of human CD34+ hematopoietic stem cells into diverse lineages including pancreatic β-cells, erythrocytes, podocytes, type-II pneumocytes, keratinocytes, chondrocytes, and megakaryocytes, contributing to the understanding of cellular plasticity and therapeutic cell generation. Parallel to this, he has made significant contributions to microbial pathogenesis, particularly on Staphylococcus aureus, elucidating molecular mechanisms of biofilm formation, metabolic regulation, and antimicrobial resistance, including MRSA, through gene expression, enzyme activity, and structure-based drug design approaches. His interdisciplinary research also addresses clinical and molecular genetics, with notable studies on mutations linked to congenital erythrocytosis, breast cancer, leukemia drug resistance, rheumatoid arthritis, tuberculosis susceptibility, cardiovascular disease, and pain genetics. During the COVID-19 period, his in silico investigations on antiviral compounds targeting SARS-CoV-2 proteins further demonstrated his adaptability across emerging biomedical challenges. He has consistently integrated wet-lab experimentation with computational biology, signaling pathways, and nanobiotechnology, including cytotoxicity studies of silver nanoparticles on human stem cells. Beyond research, he is actively involved in peer review for reputed international journals and contributes to clinical translational science through collaborations across medicine, genetics, and biotechnology. Collectively, his career reflects sustained leadership in Indian biomedical research, with impactful contributions to stem cell biology, microbial biotechnology, and molecular genetics aimed at advancing diagnostics, therapeutics, and regenerative strategies.

Profile: ORCID

Featured Publications

  1. Chandrasekhar, C., Kumar, P. S., & Sarma, P. V. G. K. (2019). Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients. Scientific Reports, 9, 38672.

  2. Loganathan, S. E., Kattaru, S., Kodavala, S., Chandrasekhar, C., & Sarma, P. V. G. K. (2024). Prominent expression of COL2A1, ACAN and IHH genes observed in the differentiation of human hematopoietic stem cells into articular type of chondrocytes. Stem Cell Reviews and Reports, 20.

  3. Kodavala, S., Loganathan, S. E., Kattaru, S., Chandrasekhar, C., & Sarma, P. V. G. K. (2024). In vitro generation of epidermal keratinocytes from human CD34-positive hematopoietic stem cells. In Vitro Cellular & Developmental Biology – Animal, 60.

  4. Suthi, S., Mounika, A., & Sarma, P. V. G. K. (2023). Elevated acetate kinase (ackA) gene expression, activity, and biofilm formation observed in methicillin-resistant strains of Staphylococcus aureus. Journal of Genetic Engineering and Biotechnology, 21.

  5. Kattaru, S., Manne Mudhu, S., Loganathan, S. E., Kodavala, S., & Sarma, P. V. G. K. (2021). Increased insulin and GLUT2 gene expression and elevated glucokinase activity in β-like cells of islets of Langerhans differentiated from human haematopoietic stem cells on treatment with Costus igneus leaf extract. Molecular Biology Reports, 48.

P. V. G. K. Sarma has advanced translational biotechnology through pioneering stem cell differentiation, molecular genetics, and microbial pathogenesis research that directly supports regenerative medicine and precision diagnostics. His work bridges laboratory science with clinical and industrial applications, contributing to improved disease understanding, therapeutic development, and global biomedical innovation.